Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding

Vascular endothelial growth factor receptor-1 (VEGFR-1) is a tyrosine kinase transmembrane receptor that has also a soluble isoform containing most of the extracellular ligand binding domain (sVEGFR-1). VEGF-A binds to both VEGFR-2 and VEGFR-1, whereas placenta growth factor (PlGF) interacts exclusi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Graziani, Grazia, Ruffini, Federica, Tentori, Lucio, Scimeca, Manuel, Dorio, Annalisa S., Atzori, Maria Grazia, Failla, Cristina M., Morea, Veronica, Bonanno, Elena, D'Atri, Stefania, Lacal, Pedro M.
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2016
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341950/
https://ncbi.nlm.nih.gov/pubmed/27655684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12108
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы